9LE-21615-35151
5 vaccinations
1 coded response
30 check-ins
1 free-text entry
2 call cases
- Sex
- —
- Age at first dose
- 31-35
- ZIP prefix
- 253 / WV
- Registered
- 2020-12-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
JGC-28746-12013
Child or adolescent in my care · Female · 2022-06-23
Timeline
-
2020-12-21
Registered in v-safe
-
2020-12-21
Dose 1 — Pfizer-BioNTech
- 2020-12-21
- 2020-12-22
- 2020-12-23
- 2020-12-24
- 2020-12-26
- 2020-12-27
- 2020-12-30
- 2021-01-04
-
2021-01-11
Dose 2 — Pfizer-BioNTech
-
2021-01-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-12
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-01-14
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-25
- 2021-02-01
- 2021-02-08
- 2021-02-15
- 2021-02-24
-
2021-08-16
Dose 3 — Pfizer-BioNTech
-
2022-01-14
Survey response — 12 months, dose 2MedDRA: Abortion spontaneous, Office visit, Uterine dilation and curettage — Feeling: Good · Get care from a doctor or other healthcare professional · HospitalizationFree text: Symptoms: Pregnant in august but miscarried at 11-12 weeks (mid October) · Healthcare visit (other): Outpatient d and cMedDRA releases: 2024-11 · check-in free text available
-
2022-01-14
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalHospitalization · 1 call case(s)
- 2022-01-18
-
2022-07-08
Dose 4 — Pfizer-BioNTech
-
2022-09-21
Dose 5 — Pfizer-BioNTechCo-administered: Flu
- 2022-09-22
- 2022-09-23
- 2022-09-25
- 2022-09-27
- 2022-09-28
- 2022-10-05
- 2022-10-12
- 2022-10-21
- 2022-10-28
- 2022-12-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-21 | Pfizer-BioNTech | |
| 2 | 2021-01-11 | Pfizer-BioNTech | |
| 3 | 2021-08-16 | Pfizer-BioNTech | No |
| 4 | 2022-07-08 | Pfizer-BioNTech | No |
| 5 | 2022-09-21 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-12 | priority 2/3 | |
| 2022-01-14 | Unsuccessful |
Free text
Release 10 — 12 months, dose 2
Symptoms: Pregnant in august but miscarried at 11-12 weeks (mid October)
Healthcare visit (other): Outpatient d and c
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| HCVO | Uterine dilation and curettage | · | · | ✓ |
| SD | Abortion spontaneous | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release